# SRX Global Inc. (SRXH) — capital_raise/private_placement [announced]
Source: SEC API (secapi.ai) · situation sit_4f418ab1feff9a3c29b6 · retrieved 2026-08-11T16:11:12.745Z

## Overview
SRX Global Inc. is a beverage company incorporated in Delaware and trading on NYSE American under ticker SRXH.

SRX Global Inc. (formerly SRx Health Solutions, Inc.) completed an additional closing on July 27, 2026 under a Securities Purchase Agreement originally entered into on March 16, 2026 with accredited investors. The company issued 4,340 shares of Series B convertible preferred stock and 284,156 warrants to purchase common stock for aggregate proceeds of approximately $3.472 million in cash. Combined with the initial closing on March 16, 2026 (5,660 Series B shares and 22,237,666 warrants for approximately $4.528 million), the company has raised approximately $8.0 million under the agreement, which permits up to 10,000 total Series B shares and accompanying warrants. The warrants were adjusted to reflect the company's 60-for-1 reverse stock split effective July 2, 2026. All securities were issued in reliance on Section 4(a)(2) of the Securities Act and/or Regulation D Rule 506.

## Terms
- Counterparty: Accredited investors · Deal value: $8.0M · Consideration: cash

## Key dates
- Announced 2026-07-28

## Timeline
- 2026-07-28 · 8-K (0001493152-26-034950): 8-K - SRX Global Inc. — *SRX Global Inc. is a beverage company incorporated in Delaware and trading on NYSE American under the ticker SRXH.* SRX Global Inc. (formerly SRx Health Solutions, Inc.) completed an additional closing on July 27, 2026 under a Securities Purchase Agreement originally entered into on March 16, 2026 with accredited investors. The company issued 4,340 shares of Series B convertible preferred stock and 284,156 warrants to purchase common stock for aggregate proceeds of approximately $3.472 million in cash. The initial closing on March 16, 2026 had generated approximately $4.528 million from the sale of 5,660 Series B preferred shares and 22,237,666 warrants. The Securities Purchase Agreement permits up to $8.0 million in aggregate purchases across one or more closings, with investors retaining the right to require additional closings for up to 4,340 additional Series B preferred shares and accompanying warrants.
  https://www.sec.gov/Archives/edgar/data/1471727/0001493152-26-034950.txt
- 2026-07-29 · 8-K/A (0001493152-26-035136): 8-K/A - SRX Global Inc. — *SRX Global Inc. is a beverage company incorporated in Delaware and trading on NYSE American under ticker SRXH.* SRX Global Inc. (formerly SRx Health Solutions, Inc.) completed an additional closing on July 27, 2026 under a Securities Purchase Agreement originally entered into on March 16, 2026 with accredited investors. The company issued 4,340 shares of Series B convertible preferred stock and 284,156 warrants to purchase common stock for aggregate proceeds of approximately $3.472 million in cash. Combined with the initial closing on March 16, 2026 (5,660 Series B shares and 22,237,666 warrants for approximately $4.528 million), the company has raised approximately $8.0 million under the agreement, which permits up to 10,000 total Series B shares and accompanying warrants. The warrants were adjusted to reflect the company's 60-for-1 reverse stock split effective July 2, 2026. All securities were issued in reliance on Section 4(a)(2) of the Securities Act and/or Regulation D Rule 506.
  https://www.sec.gov/Archives/edgar/data/1471727/0001493152-26-035136.txt

## Citations
- 0001493152-26-034950 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226034950
- 0001493152-26-035136 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226035136